WallStSmart

Dell Technologies Inc (DELL)vsEli Lilly and Company (LLY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Dell Technologies Inc generates 74% more annual revenue ($113.54B vs $65.18B). LLY leads profitability with a 31.7% profit margin vs 5.2%. DELL appears more attractively valued with a PEG of 0.65. LLY earns a higher WallStSmart Score of 80/100 (A-).

DELL

Strong Buy

78

out of 100

Grade: B+

Growth: 8.0Profit: 6.5Value: 10.0Quality: 5.8
Piotroski: 5/9

LLY

Exceptional Buy

80

out of 100

Grade: A-

Growth: 10.0Profit: 10.0Value: 9.3Quality: 8.0
Piotroski: 6/9Altman Z: 2.06
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DELLUndervalued (+69.5%)

Margin of Safety

+69.5%

Fair Value

$406.69

Current Price

$157.67

$249.02 discount

UndervaluedFair: $406.69Overvalued
LLYUndervalued (+15.6%)

Margin of Safety

+15.6%

Fair Value

$1073.59

Current Price

$906.70

$166.89 discount

UndervaluedFair: $1073.59Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DELL6 strengths · Avg: 9.5/10
Return on EquityProfitability
44.3%10/10

Every $100 of equity generates 44 in profit

Revenue GrowthGrowth
39.5%10/10

Revenue surging 39.5% year-over-year

EPS GrowthGrowth
57.3%10/10

Earnings expanding 57.3% YoY

Debt/EquityHealth
-11.9210/10

Conservative balance sheet, low leverage

Market CapQuality
$104.49B9/10

Large-cap with strong market position

PEG RatioValuation
0.658/10

Growing faster than its price suggests

LLY6 strengths · Avg: 10.0/10
Market CapQuality
$811.51B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
101.2%10/10

Every $100 of equity generates 101 in profit

Profit MarginProfitability
31.7%10/10

Keeps 32 of every $100 in revenue as profit

Operating MarginProfitability
44.9%10/10

Strong operational efficiency at 44.9%

Revenue GrowthGrowth
42.6%10/10

Revenue surging 42.6% year-over-year

EPS GrowthGrowth
51.4%10/10

Earnings expanding 51.4% YoY

Areas to Watch

DELL1 concerns · Avg: 3.0/10
Profit MarginProfitability
5.2%3/10

5.2% margin — thin

LLY3 concerns · Avg: 3.0/10
P/E RatioValuation
39.5x4/10

Premium valuation, high expectations priced in

Debt/EquityHealth
1.603/10

Elevated debt levels

Price/BookValuation
30.6x2/10

Trading at 30.6x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : DELL

The strongest argument for DELL centers on Return on Equity, Revenue Growth, EPS Growth. Revenue growth of 39.5% demonstrates continued momentum. PEG of 0.65 suggests the stock is reasonably priced for its growth.

Bull Case : LLY

The strongest argument for LLY centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 31.7% and operating margin at 44.9%. Revenue growth of 42.6% demonstrates continued momentum.

Bear Case : DELL

The primary concerns for DELL are Profit Margin.

Bear Case : LLY

The primary concerns for LLY are P/E Ratio, Debt/Equity, Price/Book. Debt-to-equity of 1.60 is elevated, increasing financial risk.

Key Dynamics to Monitor

DELL profiles as a hypergrowth stock while LLY is a growth play — different risk/reward profiles.

DELL carries more volatility with a beta of 1.04 — expect wider price swings.

LLY is growing revenue faster at 42.6% — sustainability is the question.

DELL generates stronger free cash flow (4.0B), providing more financial flexibility.

Bottom Line

LLY scores higher overall (80/100 vs 78/100), backed by strong 31.7% margins and 42.6% revenue growth. DELL offers better value entry with a 69.5% margin of safety. Both earn "Exceptional Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dell Technologies Inc

TECHNOLOGY · COMPUTER HARDWARE · USA

Dell Technologies Inc. designs, develops, manufactures, markets, sells and supports information technology solutions, products and services worldwide. The company is headquartered in Round Rock, Texas.

Visit Website →

Eli Lilly and Company

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.

Visit Website →

Want to dig deeper into these stocks?